FDA Approves CBD Treatment for Seizures in Two Rare and Severe Forms of Epilepsy
Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in patients one year of age or older. Read more about this development in Drug Topics.